体外毒性検査の世界市場（2022年～2026年）

世界の体外毒性検査の市場規模は、2022年から2026年の予測期間中に10.09％のCAGRで推移し、51億8,000万米ドルの成長が見込まれています。

同市場の成長を後押しする主な要因には、薬剤の失敗や有害物質の存在を減らすために、企業による体外毒性検査の利用が増加していることなどが挙げられます。

当レポートでは、世界の体外毒性検査市場を調査しており、市場の概要、市場規模や予測、動向、成長要因および課題、顧客情勢、エンドユーザー・地域別の分析、さらにベンダー情勢およびベンダー分析などを提供しています。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場のエコシステム
• バリューチェーン分析
  • 研究開発
  • 入力
  • 製造
  • マーケティングと販売
  • ポストセールスとサービス
  • 業界の革新

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模：2021年
• 市場の見通し：2021年から2026年の予測

第4章 ファイブフォース分析

• ファイブフォースサマリー
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• ライバルの脅威
• 市況

第5章 エンドユーザー別の市場セグメンテーション

• 市場セグメント
  • この章で取り上げるセグメントは次のとおりです。
  • o製薬およびバイオテクノロジー企業
  • o学術および研究機関
  • oその他
• エンドユーザー別比較
• 製薬およびバイオテクノロジー企業：市場規模と予測（2021年～2026年）
• 学術および調査機関：市場規模と予測（2021年～2026年）
• その他：市場規模と予測（2021年～2026年）
• エンドユーザー別市場機会

第6章 顧客情勢

• 概要

第7章 地域別情勢

• 地域別セグメンテーション
  • レポートの対象地域は次のとおりです。
  • o北米
  • o欧州
  • oアジア
  • oその他の地域
• 地域別比較
• 北米：市場規模と予測（2021年～2026年）
• 欧州：市場規模と予測（2021年～2026年）
• アジア：市場規模と予測（2021年～2026年）
• その他の地域：市場規模と予測（2021年～2026年）
• 主要国
• 地域情勢別の市場機会

第8章 促進要因、課題、および動向

• 市場促進要因
  • 薬物の失敗を減らすために企業による体外毒性検査の使用増加
  • 有毒物質の存在
  • 意識向上プログラム数の増加
• 市場の課題
  • 前臨床試験の限界
  • 限られた数の熟練した専門家
  • 厳しい規制の存在
• 市場動向
  • 毒物学の進歩
  • 化粧品需要の急増
  • 創薬への投資の増加

第9章 ベンダー情勢

• 概要
• 混乱情勢
• 競合シナリオ

第10章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abbott Laboratories
• Agilent Technologies Inc.
• Bio Rad Laboratories Inc.
• Charles River Laboratories International Inc.
• Eurofins Scientific SE
• Evotec SE
• Laboratory Corp. of America Holdings
• Merck KGaA
• SGS SA
• Thermo Fisher Scientific Inc.

第11章 付録

• 調査範囲
  • 意味
  • 目的
  • 注意事項と注意事項
• 米ドルの為替レート
• 調査手法
• 略語のリスト

Technavio has been monitoring the in-vitro toxicity testing market and it is poised to grow by $ 5.18 bn during 2022-2026 progressing at a CAGR of 10.09% during the forecast period. Our report on the in-vitro toxicity testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing use of in-vitro toxicity testing by companies to reduce drug failures and the presence of toxic substances.

The in-vitro toxicity testing market analysis includes the end-user segment and geographic landscape.

Technavio's in-vitro toxicity testing market is segmented as below:

By End-user

• Pharmaceutical and biotechnology companies
• Academic and research institutions
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• ROW

This study identifies the rising number of awareness programsas one of the prime reasons driving the in-vitro toxicity testing market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on in-vitro toxicity testing market covers the following areas:

• In-vitro toxicity testing market sizing
• In-vitro toxicity testing market forecast
• In-vitro toxicity testing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro toxicity testing market vendors that include Abbott Laboratories, Agilent Technologies Inc., Bio Rad Laboratories Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, Laboratory Corp. of America Holdings, Merck KGaA, SGS SA, and Thermo Fisher Scientific Inc. Also, the in-vitro toxicity testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1. Executive Summary

• 1.1 Market overview

2. Market Landscape

• 2.1 Market ecosystem
• Exhibit 08: Parent market
• Exhibit 09: Market characteristics
• 2.2 Value chain analysis
• Exhibit 10: Value chain analysis - Life sciences tools and services
  • 2.2.1Research and development
  • 2.2.2 Inputs
  • 2.2.3 Production
  • 2.2.5 Marketing and sales
  • 2.2.6 Post-sales and services
  • 2.2.7 Industry innovations

3. Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021 - 2026
• Exhibit 13: Global - Market size and forecast 2021 - 2026 ($ million)
• Exhibit 14: Global market: Year-over-year growth 2021-2026 (%)

4. Five Forces Analysis

• 4.1 Five Forces Summary
• Exhibit 15: Five forces analysis 2021 & 2026
• 4.2 Bargaining power of buyers
• Exhibit 16: Bargaining power of buyers
• 4.3 Bargaining power of suppliers
• Exhibit 17: Bargaining power of suppliers
• 4.4 Threat of new entrants
• Exhibit 18: Threat of new entrants
• 4.5 Threat of substitutes
• Exhibit 19: Threat of substitutes
• 4.6 Threat of rivalry
• Exhibit 20: Threat of rivalry
• 4.7 Market condition
• Exhibit 21: Market condition - Five forces 2021

5. Market Segmentation by End-user

• 5.1 Market segments
  • The segments covered in this chapter are:
  • o Pharmaceutical and biotechnology companies
  • o Academic and research institutions
  • o Others
• Exhibit 22: End-user - Market share 2021-2026 (%)
• 5.2 Comparison by End-user
• Exhibit 23: Comparison by end-user
• 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
• Exhibit 24: Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
• Exhibit 25: Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
• 5.4 Academic and research institutions - Market size and forecast 2021-2026
• Exhibit 26: Academic and research institutions - Market size and forecast 2021-2026 ($ million)
• Exhibit 27: Academic and research institutions - Year-over-year growth 2021-2026 (%)
• 5.5 Others - Market size and forecast 2021-2026
• Exhibit 28: Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Others - Year-over-year growth 2021-2026 (%)
• 5.6 Market opportunity by end-user
• Exhibit 30: Market opportunity by end-user

6. Customer landscape

• 6.1 Overview
• Exhibit 31: Customer landscape

7. Geographic Landscape

• 7.1 Geographic segmentation
  • The regions covered in the report are:
  • o North America
  • o Europe
  • o Asia
  • o ROW
• Exhibit 32: Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 33: Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 34: North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 35: North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 36: Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 38: Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 39: Asia - Year-over-year growth 2021-2026 (%)
• 7.6 ROW - Market size and forecast 2021-2026
• Exhibit 40: ROW - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: ROW - Year-over-year growth 2021-2026 (%)
• 7.7 Key leading countries
• Exhibit 42: Key leading countries
• 7.8 Market opportunity By Geographical Landscape
• Exhibit 43: Market opportunity By Geographical Landscape ($ million)

8. Drivers, Challenges, and Trends

• 8.1 Market drivers
  • 8.1.1 Increasing use of in-vitro toxicity testing by companies to reduce drug failures
  • 8.1.2 Presence of toxic substances
  • 8.1.3 Rising number of awareness programs
• 8.2 Market challenges
  • 8.2.1 Limitations of preclinical studies
  • 8.2.2 Limited number of skilled professionals
  • 8.2.3 Presence of stringent regulations
• Exhibit 44: Impact of drivers and challenges
• 8.3 Market trends
  • 8.3.1 Advances in toxicology
  • 8.3.2 Surge in demand for cosmetics
  • 8.3.3 Increasing investments in drug discovery

9. Vendor Landscape

• 9.1 Overview
• Exhibit 45: Vendor landscape
• 9.2 Landscape disruption
• Exhibit 46: Landscape disruption
• Exhibit 47: Industry risks
• 9.3 Competitive scenario

10. Vendor Analysis

• 10.1 Vendors covered
• Exhibit 48: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 49: Market positioning of vendors
• 10.3 Abbott Laboratories
• Exhibit 50: Abbott Laboratories - Overview
• Exhibit 51: Abbott Laboratories - Business segments
• Exhibit 52: Abbott Laboratories - Key news
• Exhibit 53: Abbott Laboratories - Key offerings
• Exhibit 54: Abbott Laboratories - Segment focus
• 10.4 Agilent Technologies Inc.
• Exhibit 55: Agilent Technologies Inc. - Overview
• Exhibit 56: Agilent Technologies Inc. - Business segments
• Exhibit 57: Agilent Technologies Inc. - Key news
• Exhibit 58: Agilent Technologies Inc. - Key offerings
• Exhibit 59: Agilent Technologies Inc. - Segment focus
• 10.5 Bio Rad Laboratories Inc.
• Exhibit 60: Bio Rad Laboratories Inc. - Overview
• Exhibit 61: Bio Rad Laboratories Inc. - Business segments
• Exhibit 62: Bio Rad Laboratories Inc. - Key news
• Exhibit 63: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 64: Bio Rad Laboratories Inc. - Segment focus
• 10.6 Charles River Laboratories International Inc.
• Exhibit 65: Charles River Laboratories International Inc. - Overview
• Exhibit 66: Charles River Laboratories International Inc. - Business segments
• Exhibit 67: Charles River Laboratories International Inc. - Key offerings
• Exhibit 68: Charles River Laboratories International Inc. - Segment focus
• 10.7 Eurofins Scientific SE
• Exhibit 69: Eurofins Scientific SE - Overview
• Exhibit 70: Eurofins Scientific SE - Business segments
• Exhibit 71: Eurofins Scientific SE - Key news
• Exhibit 72: Eurofins Scientific SE - Key offerings
• Exhibit 73: Eurofins Scientific SE - Segment focus
• 10.8 Evotec SE
• Exhibit 74: Evotec SE - Overview
• Exhibit 75: Evotec SE - Business segments
• Exhibit 76: Evotec SE - Key offerings
• Exhibit 77: Evotec SE - Segment focus
• 10.9 Laboratory Corp. of America Holdings
• Exhibit 78: Laboratory Corp. of America Holdings - Overview
• Exhibit 79: Laboratory Corp. of America Holdings - Business segments
• Exhibit 80: Laboratory Corp. of America Holdings - Key offerings
• Exhibit 81: Laboratory Corp. of America Holdings - Segment focus
• 10.10 Merck KGaA
• Exhibit 82: Merck KGaA - Overview
• Exhibit 83: Merck KGaA - Business segments
• Exhibit 84: Merck KGaA- Key news
• Exhibit 85: Merck KGaA - Key offerings
• Exhibit 86: Merck KGaA - Segment focus
• 10.11 SGS SA
• Exhibit 87: SGS SA - Overview
• Exhibit 89: SGS SA - Key news
• Exhibit 90: SGS SA - Key offerings
• Exhibit 91: SGS SA - Segment focus
• 10.12 Thermo Fisher Scientific Inc.
• Exhibit 92: Thermo Fisher Scientific Inc. - Overview
• Exhibit 93: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 94: Thermo Fisher Scientific Inc. - Key news
• Exhibit 95: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 96: Thermo Fisher Scientific Inc. - Segment focus

11. Appendix

• 11.1 Scope of the report
  • 11.1.1 Definition
  • 11.1.2 Objectives
  • 11.1.3 Notes and caveats
• 11.2 Currency conversion rates for US$
• Exhibit 97: Currency conversion rates for US$
• 11.3 Research Methodology
• Exhibit 98: Research Methodology
• Exhibit 99: Validation techniques employed for market sizing
• Exhibit 100: Information sources
• 11.4 List of abbreviations
• Exhibit 101: List of abbreviations

Exhibits

• Exhibits1: Key Finding 1
• Exhibits2: Key Finding 2
• Exhibits3: Key Finding 3
• Exhibits4: Key Finding 5
• Exhibits5: Key Finding 6
• Exhibits6: Key Finding 7
• Exhibits7: Key Finding 8
• Exhibits8: Parent market
• Exhibits9: Market characteristics
• Exhibits10: Offerings of vendors included in the market definition
• Exhibits11: Market segments
• Exhibits12: Global - Market size and forecast 2021 - 2026 ($ million)
• Exhibits13: Global market: Year-over-year growth 2021 - 2026 (%)
• Exhibits14: Five forces analysis 2021 & 2026
• Exhibits15: Bargaining power of buyers
• Exhibits16: Bargaining power of suppliers
• Exhibits17: Threat of new entrants
• Exhibits18: Threat of substitutes
• Exhibits19: Threat of rivalry
• Exhibits20: Market condition - Five forces 2021
• Exhibits21: End-user - Market share 2021-2026 (%)
• Exhibits22: Comparison by End-user
• Exhibits23: Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
• Exhibits24: Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
• Exhibits25: Academic and research institutions - Market size and forecast 2021-2026 ($ million)
• Exhibits26: Academic and research institutions - Year-over-year growth 2021-2026 (%)
• Exhibits27: Others - Market size and forecast 2021-2026 ($ million)
• Exhibits28: Others - Year-over-year growth 2021-2026 (%)
• Exhibits29: Market opportunity by End-user
• Exhibits30: Customer landscape
• Exhibits31: Market share By Geographical Landscape 2021-2026 (%)
• Exhibits32: Geographic comparison
• Exhibits33: North America - Market size and forecast 2021-2026 ($ million)
• Exhibits34: North America - Year-over-year growth 2021-2026 (%)
• Exhibits35: Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits36: Europe - Year-over-year growth 2021-2026 (%)
• Exhibits37: Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Asia - Year-over-year growth 2021-2026 (%)
• Exhibits39: ROW - Market size and forecast 2021-2026 ($ million)
• Exhibits40: ROW - Year-over-year growth 2021-2026 (%)
• Exhibits41: Key leading countries
• Exhibits42: Market opportunity By Geographical Landscape ($ million)
• Exhibits43: Impact of drivers and challenges
• Exhibits44: Vendor landscape
• Exhibits45: Landscape disruption
• Exhibits46: Industry risks
• Exhibits47: Vendors covered
• Exhibits48: Market positioning of vendors
• Exhibits49: Abbott Laboratories - Overview
• Exhibits50: Abbott Laboratories - Business segments
• Exhibits51: Abbott Laboratories - Key offerings
• Exhibits52: Abbott Laboratories - Key customers
• Exhibits53: Abbott Laboratories - Segment focus
• Exhibits54: Agilent Technologies Inc. - Overview
• Exhibits55: Agilent Technologies Inc. - Business segments
• Exhibits56: Agilent Technologies Inc. - Key offerings
• Exhibits57: Agilent Technologies Inc. - Key customers
• Exhibits58: Agilent Technologies Inc. - Segment focus
• Exhibits59: Bio Rad Laboratories Inc. - Overview
• Exhibits60: Bio Rad Laboratories Inc. - Business segments
• Exhibits61: Bio Rad Laboratories Inc. - Key offerings
• Exhibits62: Bio Rad Laboratories Inc. - Key customers
• Exhibits63: Bio Rad Laboratories Inc. - Segment focus
• Exhibits64: Charles River Laboratories International Inc. - Overview
• Exhibits65: Charles River Laboratories International Inc. - Business segments
• Exhibits66: Charles River Laboratories International Inc. - Key offerings
• Exhibits67: Charles River Laboratories International Inc. - Key customers
• Exhibits68: Charles River Laboratories International Inc. - Segment focus
• Exhibits69: Eurofins Scientific SE - Overview
• Exhibits70: Eurofins Scientific SE - Business segments
• Exhibits71: Eurofins Scientific SE - Key offerings
• Exhibits72: Eurofins Scientific SE - Key customers
• Exhibits73: Eurofins Scientific SE - Segment focus
• Exhibits74: Evotec SE - Overview
• Exhibits75: Evotec SE - Business segments
• Exhibits76: Evotec SE - Key offerings
• Exhibits77: Evotec SE - Key customers
• Exhibits78: Evotec SE - Segment focus
• Exhibits79: Laboratory Corp. of America Holdings - Overview
• Exhibits80: Laboratory Corp. of America Holdings - Business segments
• Exhibits81: Laboratory Corp. of America Holdings - Key offerings
• Exhibits82: Laboratory Corp. of America Holdings - Key customers
• Exhibits83: Laboratory Corp. of America Holdings - Segment focus
• Exhibits84: Merck KGaA - Overview
• Exhibits85: Merck KGaA - Business segments
• Exhibits86: Merck KGaA - Key offerings
• Exhibits87: Merck KGaA - Key customers
• Exhibits88: Merck KGaA - Segment focus
• Exhibits89: SGS SA - Overview
• Exhibits90: SGS SA - Business segments
• Exhibits91: SGS SA - Key offerings
• Exhibits92: SGS SA - Key customers
• Exhibits93: SGS SA - Segment focus
• Exhibits94: Thermo Fisher Scientific Inc. - Overview
• Exhibits95: Thermo Fisher Scientific Inc. - Business segments
• Exhibits96: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits97: Thermo Fisher Scientific Inc. - Key customers
• Exhibits98: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits99: Currency conversion rates for US$
• Exhibits100: Research Methodology
• Exhibits101: Validation techniques employed for market sizing
• Exhibits102: Information sources
• Exhibits103: List of abbreviations